![]() |
| |||||||||||
MDPI AG - Pharmaceuticals 2012 : Special Issue: Cell-penetrating Peptides - Pharmaceuticals (ISSN 1424-8247) | |||||||||||
Link: http://www.mdpi.com/si/pharmaceuticals/peptides/ | |||||||||||
| |||||||||||
Call For Papers | |||||||||||
Dear colleagues,
The following Special Issue will be published in Pharmaceuticals (http://www.mdpi.com/journal/pharmaceuticals/, ISSN 1424-8247), and is now open to receive submissions of full research papers and comprehensive review articles for peer-review and possible publication: Special Issue: Cell-penetrating Peptides Website: http://www.mdpi.com/si/pharmaceuticals/peptides/ Guest Editor: Prof. Dr. Vladimir P. Torchilin Deadline for manuscript submissions: 30 September 2012 You may send your manuscript now or up until the deadline. Submitted papers should not have been published previously, nor be under consideration for publication elsewhere. We also encourage authors to send us their tentative title and short abstract by e-mail for approval to the Editorial Office at pharmaceuticals@mdpi.com. This Special Issue will be fully open access. Open access (unlimited and free access by readers) increases publicity and promotes more frequent citations as indicated by several studies. Open access is supported by the authors and their institutes. More information is available at http://www.mdpi.com/about/openaccess/. Article Processing Charges are 500 CHF per accepted article. An additional fee of 250 CHF may apply if English editing or extensive revisions must be undertaken by the Editorial Office. More information can be found at http://www.mdpi.com/about/apc/. Pharmaceuticals (ISSN 1424-8247) is an international, peer-reviewed open access journal on pharmaceutical sciences, including molecular medicine. Pharmaceuticals is published by MDPI online monthly. Please visit the Instructions for Authors website before submitting a paper at http://www.mdpi.com/journal/pharmaceuticals/instructions/. Manuscripts should be submitted through the online manuscript submission and editorial system at http://www.mdpi.com/user/manuscripts/upload/. MDPI publishes several peer-reviewed, open access journals listed at http://www.mdpi.com/. The Editorial Board members, including several Nobel Laureates (http://www.mdpi.com/about/nobelists/), are all leading active scholars. All MDPI journals maintain rapid, yet rigorous, peer- review, manuscript handling and editorial processes. MDPI journals have increased their impact factors, see "2010 Newly Released Impact Factors", http://www.mdpi.com/about/announcements/121/. In case of questions, please contact the Editorial Office at: pharmaceuticals@mdpi.com We are looking forward to hearing from you. Kind regards, MDPI AG On behalf of the Guest Editor Prof. Dr. Vladimir P. Torchilin Center for Pharmaceutical Biotechnology and Nanomedicine Northeastern University, Mugar Hall, Room 312 360 Huntington Avenue Boston, MA 02115 USA Website: http://www.northeastern.edu/bouve/faculty/torchilin_v.html E-Mail: v.torchilin@neu.edu -- Editor-in-Chief of Pharmaceuticals Dr. Derek J. McPhee E-Mail: mcphee@mdpi.com -- MDPI AG Kandererstrasse 25 CH-4057 Basel, Switzerland Tel. +41 61 683 77 34 Fax: +41 61 302 89 18 E-Mail: pharmaceuticals@mdpi.com http://www.mdpi.com/ |
|